Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Automated Sample and Liquid Handling Platforms Suited for All Lab Sizes

By BiotechDaily International staff writers
Posted on 08 Jul 2014
Tecan Fluent laboratory automation solution
Automated Sample and Liquid Handling Platform (Photo courtesy of TECAN GROUP LTD.)
Biotech and other life scientists who work with cell-based assays now have available a new line of advanced automated sample and liquid handling platforms.

Tecan (Männedorf, Switzerland) has introduced the Fluent laboratory automation solution, the latest addition to its laboratory automation portfolio.

The Fluent system is available in three sizes—offering deck capacities from 30 to 72 microplates—to suit the throughput requirements of almost any laboratory. The instrument boasts a built-in touchscreen interface that guides users through every task, making even the most sophisticated cell-based assays easy to run. Fluent’s three, task-specific robotic arms work in parallel for faster processing, and offer automated lid handling to maintain sterility and minimize evaporation.

The Fluent platform was designed for integration with a variety of cell biology devices. This allows the user to control every step of the workflow, including storage, transfer, manipulation, and measurement of cellular samples on a single instrument.

The Tecan HydroSpeed plate washer features extra-gentle wash settings that can be adjusted to suit specific cells, microplates, and applications, ensuring reproducible results even with weakly adherent cells.

“Today’s research landscape looks different from yesterday’s, with customers wanting systems that are faster, more versatile, and more cost efficient,” said Dr. Stefan Traeger, head of life sciences business at Tecan. “The Fluent laboratory automation solution has initially been developed to address the needs of cell biology laboratories as they move towards greater miniaturization and higher throughput assays, and our test sites and assay partners have been impressed by its speed and capabilities for automating even complex cell-based assays.”

Related Links:

Tecan




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A leukemia cell coated with antibody is marked for destruction by activated natural killer cells (Photo courtesy of the University of Southern California).

Leukemia Cells Are Killed in Culture by Immune Cells Grown from the Same Patient

Immune system natural killer (NK) cells were isolated from leukemia patients, expanded in culture, and then shown in an in vitro system to attack and destroy cancer cells from the original cell donors.... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.